2026 Helen J. Lachmann: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	105	6803	6397	657	627	630	38498

Helen J. Lachmann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Helen J. Lachmann sits on this spectrum.

101 publications 1,796+

This scientist: 630 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Helen J. Lachmann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Helen J. Lachmann sits on this spectrum.

70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Helen J. Lachmann is affiliated with University College London in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on areas such as Molecular Biology, Nephrology, Immunology, Rheumatology, and Genetics.

Their work addresses multiple topics, including:

Amyloidosis: Diagnosis, Treatment, Outcomes
Parathyroid Disorders and Treatments
Inflammasome and immune disorders
Neuroendocrine Tumor Research Advances
Medical Imaging and Pathology Studies
Autoimmune and Inflammatory Disorders Research
Peptidase Inhibition and Analysis

Helen J. Lachmann has contributed to recent publications in high-impact journals. Notable papers include:

"Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease," 2020, New England Journal of Medicine
"Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review," 2020, TURKISH JOURNAL OF MEDICAL SCIENCES
"Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years," 2022, Circulation
"Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19," 2021, JAMA
"Epidemiologic and Survival Trends in Amyloidosis, 1987-2019," 2020, New England Journal of Medicine

Frequent co-authors collaborating with Lachmann feature:

Philip N. Hawkins
Julian D. Gillmore
Ashutosh Wechalekar
Carol Whelan
Ana Martinez-Naharro

Their research outputs are often published in venues such as:

European Heart Journal
Circulation
European Journal of Heart Failure
British Journal of Haematology
Blood

Best Publications

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

1700
Citations
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

David B. Beck;Marcela A. Ferrada;Keith A. Sikora;Amanda K. Ombrello

1059
Citations
Natural history and outcome in systemic AA amyloidosis.

Helen J Lachmann;Hugh J B Goodman;Janet A Gilbertson;J Ruth Gallimore

1018
Citations
Use of canakinumab in the cryopyrin-associated periodic syndrome.

Helen J Lachmann;Isabelle Kone-Paut;Jasmin B Kuemmerle-Deschner;Kieron S Leslie

970
Citations
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Helen J Lachmann;David R Booth;Susanne E Booth;Alison Bybee

768
Citations
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra

Philip N. Hawkins;Helen J. Lachmann;Ebun Aganna;Michael F. McDermott

680
Citations
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

M. B. Pepys;J. Herbert;W. L. Hutchinson;G. A. Tennent

637
Citations
The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

Markus G. Seidel;Gerhard Kindle;Benjamin Gathmann;Isabella Quinti

588
Citations
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

Marianna Fontana;Silvia Pica;Patricia Reant;Amna Abdel-Gadir

556
Citations
A new staging system for cardiac transthyretin amyloidosis

Julian D Gillmore;Thibaud Damy;Marianna Fontana;Matthew Hutchinson

548
Citations
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

Philip N. Hawkins;Helen J. Lachmann;Michael F. McDermott

534
Citations
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells

Giuseppina Arbore;Erin E. West;Rosanne Spolski;Avril A. B. Robertson

532
Citations
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Helen J. Lachmann;Ruth Gallimore;Julian D. Gillmore;Hugh D. Carr-Smith

528
Citations
Classification criteria for autoinflammatory recurrent fevers

Marco Gattorno;Michael Hofer;Silvia Federici;Federica Vanoni

522
Citations
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.

Ebun Aganna;Fabio Martinon;Philip N. Hawkins;John B. Ross

496
Citations
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

Fabrizio De Benedetti;Marco Gattorno;Jordi Anton;Eldad Ben-Chetrit

482
Citations
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

Nienke Ter Haar;Helen Lachmann;Seza Özen;Pat Woo

478
Citations
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Nelson Leung;Frank Bridoux;Vecihi Batuman;Aristeidis Chaidos

452
Citations
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

H. J. Lachmann;B. Şengül;T. U. Yavuzşen;D. R. Booth

426
Citations
Native T1 mapping in transthyretin amyloidosis

Marianna Fontana;Sanjay M. Banypersad;Thomas A. Treibel;Viviana Maestrini

424
Citations

Frequent Co-Authors

Julian D. Gillmore University College London

Marco Gattorno Istituto Giannina Gaslini

Philip N. Hawkins University College London

Anna Simon Christian Medical College & Hospital

Seza Ozen Hacettepe University

James C. Moon University College London

Giampaolo Merlini University of Pavia

Ahmet Gül Istanbul University

Mark B. Pepys University College London

Claudia Kemper National Institutes of Health

External Links

Personal website of Helen J. Lachmann

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Many students interested in Medicine explore various online degrees in healthcare to broaden their career opportunities. One popular route involves pursuing online nursing doctoral programs, which equip graduates for advanced practice, teaching, or leadership roles in healthcare.

For registered nurses seeking to advance their skills affordably, cheapest online bsn programs offer flexibility and cost savings without sacrificing educational quality. These programs often appeal to working professionals who want to further their credentials.

Individuals from non-nursing backgrounds also have options. msn direct entry programs online allow those holding a non-nursing bachelor’s degree to earn a master’s degree in nursing and enter the field more quickly.

If you’re considering a more straightforward path into nursing, direct entry nursing programs can provide accessible admissions for aspiring nurses. Each pathway helps students meet the increasing demand for healthcare professionals while offering the flexibility of online learning.